Figure 1. Research Method Flow Chart 9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14
Figure 4. North America Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 16
Figure 5. Impact of COVID-19 on Business 19
Figure 6. Primary Drivers and Impact Factors of North America Diagnostic Specialty Antibodies Market 21
Figure 7. Primary Restraints and Impact Factors of North America Diagnostic Specialty Antibodies Market 24
Figure 8. Investment Opportunity Analysis 28
Figure 9. Porter’s Fiver Forces Analysis of North America Diagnostic Specialty Antibodies Market 31
Figure 10. Breakdown of North America Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue 35
Figure 11. Contribution to North America 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%) 36
Figure 12. North America Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn 37
Figure 13. North America Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn 38
Figure 14. North America Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn 39
Figure 15. Breakdown of North America Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue 40
Figure 16. Contribution to North America 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%) 41
Figure 17. North America Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn 42
Figure 18. North America Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn 43
Figure 19. North America Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn 44
Figure 20. North America Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn 45
Figure 21. North America Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn 46
Figure 22. North America Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn 47
Figure 23. North America Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn 48
Figure 24. Breakdown of North America Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue 49
Figure 25. Contribution to North America 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%) 50
Figure 26. North America Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn 51
Figure 27. North America Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn 52
Figure 28. North America Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn 53
Figure 29. Breakdown of North America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue 55
Figure 30. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 56
Figure 31. U.S. Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 58
Figure 32. Canada Diagnostic Specialty Antibodies Market, 2017-2027, $ mn 60
Figure 33. Diagnostic Specialty Antibodies Market in Mexico, 2017-2027, $ mn 62
Figure 34. Growth Stage of North America Diagnostic Specialty Antibodies Industry over the Forecast Period 64
North America diagnostic specialty antibodies market is expected to grow by 4.2% annually in the forecast period and reach $10.86 billion by 2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer. Highlighted with 20 tables and 34 figures, this 84-page report “North America Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire North America diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Country. Based on Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Monoclonal Antibodies • Polyclonal Antibodies • Other Types Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Oncology Diagnosis • Hepatitis Diagnosis • Infectious Disease Diagnosis • Dengue Diagnostics • Tuberculosis Diagnostics • HIV Diagnostics • Other Applications Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hospitals & Clinics • Diagnostic Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Type, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Abcam plc Agilent Technologies, Inc. Aytu BioScience, Inc. Becton, Dickinson and Company Bio-Rad Laboratories, Inc. Boehringer Ingelheim International GmbH Creative Diagnostics Enzo Life Sciences, Inc. F. Hoffmann-La Roche AG Merck KGaA Polymun Scientific Immunbiologische Forschung GmbH Sanofi S.A. Sartorius AG Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More